Just let them talk. Good afternoon everybody. It's a great pleasure to welcome you all here. And Eurofarma, a 54-year-old company, is here today showcasing our complex, our industrial complex in Montes Claros, which is already partially operational, right? Our company, Eurofarma, is a Brazilian multinational company with a presence in 24 countries. Furthermore, I would like to greet Laudemir, who is here at Apex, right, Laudemir, who always helps us in the internalization process. I don't know if the ambassador, I don't know if Ambassador Jaccomelli is here too, but I also wanted to greet him, I also wanted to greet Itamaraty, which helped us a lot in this internationalization process. Mr. President, and this complex here, a 250,000 square meter complex, which is already operational. You can come, you had financing from Banco do Nordeste, and greet the president, Paulo Câmara, here. And today, Mr. President, Eurofarma manufactures 600 million boxes of medicine annually. That's 15 billion pills. In other words, all of this is to increase access for the population by producing generic drugs. producing high-quality medicines and also to greet Anvisa, director Marcelo Moreira is here, which has this important role of guaranteeing the safety and quality of medicines in Brazil. I would also like to mention, Mr. President, the importance of these people who are here, our employees who work at Eurofarma. This is our greatest asset. Our greatest asset is them, Mr. President, precisely the employees of LOFARM. For them, Eurofarma offers a range of professional training benefits. Back there, Mr. President, we have the daycare center for the employees' children. We have a gym there so everyone can get ripped like Minister Padilha, right? President, right? So, Mr. President, that's precisely why we've been among the best companies to work for for 20 consecutive years. So, a very important asset we have is our 13,000 employees. Yes, in addition, Eurofarma also has very important social projects. We have the Eurofarma Institute, which serves underprivileged children and young people, providing vocational training and instruction. We have already served more than 200,000 young people and children in these programs that we have at the company. And finally, we also have, as Minister Padilha has already visited us, an innovation center in São Paulo with over 700 scientists who are conducting research and developing high- quality medicines. Last year we invested millions of reais in innovation alone, precisely to bring more quality, more new products, new medicines, even making radical innovations for the country. So, in that sense, Mr. President, I want to thank you very much , and also Minister Padilha, who leads all this public policy in the area of ​​health for our pharmaceutical sector, and say that this certainly promotes the country's development, creates jobs in the country, develops research and development in the country, and improves the population's access to quality medicines. Now it's up to the president of Banco do Nordeste, Paulo Câmara, to speak. Good afternoon everybody. I would like to greet President Lula, Ministers Padilha and Alexandre Silveira, and everyone at Elofarma here on behalf of President Maurício, and say, Mr. President, that the Banco do Nordeste, in addition to operating in the nine states of the Northeast region, also had the privilege of operating in 249 municipalities here in Minas Gerais. And we are acting, Mr. President, in the way you instructed. We are arriving with productive microcredit oriented towards the CRED Amigo program, in the Agroamigo program. We are active in small micro-enterprises, family farming, agribusiness, commerce, services, tourism, and large infrastructure projects. And today we also have the privilege of being a partner of Eurofarma, a partner since it arrived here in Montes Claros, and a partner that has undoubtedly helped the pharmaceutical hub here in northern Minas Gerais to become a benchmark for all of Brazil, generating employment, income, and being included in the New Industry Brazil program. It is a sustainable, productive industry that generates quality jobs, has an excellent workforce, and has greatly helped the health of Brazil, the SUS (Unified Health System), and the popular pharmacy program. And Banco do Nordeste is very proud of that. Under your administration, we are already funding 50% more than the previous administration did. This is the result of his guidance, of looking out for everyone, and especially of generating development, generating income, and creating many quality jobs. So, I am very happy to be able, as president of Banco Nordeste, to also help the north of Minas Gerais and help this region to become an increasingly important reference point for Brazil, with hardworking people and increasingly consolidated in the forum, in the field of producing medicines for the population that needs them most in Brazil. Thank you very much. And count on Banco do Nordeste. At this moment, the Minister of Health, Alexandre Padilha, will give a presentation on pharmaceutical assistance and the industrial complex. Good afternoon. Good afternoon everyone. Good afternoon everybody. And here I want, first of all, on behalf of the Ministry of Health, to say a big thank you to the workers of Eurofarma, of this large complex here. My mission will be to give a presentation, if we could step aside for a moment, to show each of you, to show our fellow parliamentarians who are here, to show the people at Anvisa who know and understand this very well, to our colleagues at PEC, which is the agency that promotes products for export in foreign trade, to our BNB, Banco do Nordeste, to our dear Minister Saraiva, how what you produce, your production, reaches the hands of those who need it most in this country. It's a marriage between health, the care for people's health , relief in the pockets of families, because each medicine produced here in Brazil means a lower price and inclusion in the SUS (Brazilian Public Health System), and the generation of jobs, income, and technology. This complex here today, Mr. President, employs nearly 400 workers , but it will reach 3,000 workers, generating jobs and boosting the economy. Let's move on to the next one, then, so we can understand where this marriage between production and health begins. One of the symbols of this partnership is the Farmácia Popular program, which was created by President Lula and expanded by Minister Saraiva Felipe at the time. It's a partnership between the Ministry of Health and private pharmacies throughout Brazil. This program, Mr. President, has now reached, we've reached, in 2025, a record number of users. We have reached 27,300,000 Brazilians who obtain this medication at the public pharmacy. Today this medication is 100% free, because there was a period when they invented a system where they charged people a portion of it. The gentleman thankfully returned and arranged for this medication to be delivered completely free of charge. Today there are 41 items, not only medications, but also feminine hygiene products for women through the Menstrual Dignity program. There are many young teenage girls who don't have access to sanitary pads, sometimes they miss school or work because of it, but now they can get them at the public pharmacy through the menstrual hygiene program, as well as adult diapers. It's a program where today, Mr. President, 61% of the users are people over 60 years old. It's a program that protects the elderly in Brazil, and thankfully, we're going to have more and more elderly people in our country because we're going to live longer and longer, right? The longer we live, the greater the demand for medication, the greater the need for healthcare. And the vast majority are women. 63% of users of the "Farmácia Popular" program are women, meaning it's a program that protects women. I said 27 million by 2025, that was until December 2025, a great growth. When we look at the first six months of this year, we've already reached 22 million. This shows that we will probably reach over 30 million users of the Farmácia Popular program by the end of the year. So what is the connection between the Farmácia Popular program and a factory like that? Seven medications from the Farmácia Popular program are produced here. There used to be a public pharmacy program to provide access to medication for our people. The fact that 27 million people can get this medication paid for by the Ministry of Health is what generates the demand for Walker, for Maurício, and for the workers at Eurofarma to expand production here in Brazil. And we can only make this pharmaceutical drug available because you in the national industry produce it, generating jobs and income. One example is dapa glifosine, which is a medication that was there, but only one international company was producing it, making it too expensive for the ministry and difficult for us to expand production. So the Ministry of Health, along with Anvisa (Marcelo is here), we called the companies and encouraged them to register and produce the generic version. The DAP box is right there, there's a box behind it. You produced the generic version here, and we're going to put it in the public pharmacy program. And today, Eurofarma is one of the companies, along with other national companies, that helped us to get dfosine into the popular pharmacy program. To give you an idea, Mr. President, you asked me inside the factory, and I went to... I'm going to talk, and I'm waiting for the box to arrive there. You asked, yes, this medication is a modern medication for diabetes. People with diabetes who are not currently taking this medication could benefit from it. It is a medication that greatly helps those who have both diabetes and cardiovascular problems. It's a medication that only one international company produced here in Brazil. Companies like Eurofarma have taken on the challenge, and today the staff were showing me here that 500,000 units, half a million units, come out of this complex here in Montes Claros. That's 15 million tablets, thanks to the work and effort of each one of you. We distribute around 60 million doses throughout Brazil, and a significant portion comes from Eurofarma. Mr. President, this happened with DAPO. This also happens with other medications sold at popular pharmacies. Yes, sir, you've brought the "Farmácia Popular" program back to growth, but now we're discussing something new within the "Farmácia Popular" program. Then the Novo staff came over and took a picture with you guys. Wait a moment. There's something new happening at the Farmácia Popular (Popular Pharmacy). Mr. President, we held a meeting at your request, and a working group was formed with associations of medicines, laboratories, and pharmacies to discuss innovations in the popular pharmacy program. One of the ideas that came up in that meeting is that, in addition to having medication, the "Farmácia Popular" ( Popular Pharmacy) could also offer people the possibility of having blood and urine tests, and consultations with doctors, nutritionists, nurses, and physiotherapists via telemedicine. So that's one of the ideas that's emerging there. I'll tell you this, sir , okay? from apoglyphosine here. This name here is difficult to understand; let me show you that it was a medication produced only by one international company. The Brazilian national industry has taken on the challenge of producing this medication here. It is produced here in Montes Claros. Here, Mr. President, I am here. Today, 500,000 units of this little box are shipped out every month here in Montes Claros. arriving. That amounts to 15 million pills in the public pharmacy program. Across all government-run pharmacies, we distribute 60 million of these pills. Mr. President, if someone had bought this before, they would have paid R$150 or R$200 per month for this medication. Thanks to the public pharmacy program, she doesn't have to pay anything. Pick it up at the public pharmacy without having to pay. Moreover, a family today that has four Brazilians still in the family, one with high blood pressure , another with diabetes, another who is an elderly person who needs adult diapers, a young woman who takes sanitary pads, saves, Mr. President, R$ 9,000 per year thanks to the popular pharmacy program. It's half the minimum wage per month that a person has to spend, and with that, they can put some relief in their pocket, use that money for other expenses, or take care of their child. This is thanks to President Lula's decision and the work of each and every one of you here in this factory. It's not just the Popular Pharmacy program, Mr. President. Let me have dinner with her there, sir, would you like to stay with her? It 's not just the Popular Pharmacy program. You can move on to the next one. Other ways in which we deliver medication through the SUS (Brazilian public healthcare system) also influence the industry. Part of the industry here, Mr. President, produces other medications that enter the SUS (Brazilian public healthcare system) through other means, which is our entire pharmaceutical assistance program. Today, there are 690 medications and supplies that rally participants are entitled to receive without having to pay. Just so you have an idea, since 2023, the first year of your administration, 165 more medications have been added. Here we have medications for cancer, medications for chronic kidney disease, medications for those who are in the hospital. One of these included, Mr. President, are 23 new medications for cancer treatment, which had been expected to be included for decades and are now in the SUS (Brazilian Public Health System), meaning that the SUS is offering the most modern treatments available. I'm talking about medications for cancer treatment here; some of them cost R$50,000, R$100,000, or even R$1,000 for treatment, and now it's a right under the Unified Health System (SUS). That's what prompts national industries like this one, or even international ones, to come and produce here in Brazil. This meant an increase in investment in pharmaceutical assistance within the SUS (Brazilian Public Health System). Mr. President, just so you know, this place was practically frozen in time. Between 2016 and 2022, the Ministry of Health's investment in the purchase of medicines was practically frozen. What was happening here during that period? so-called spending cap, which froze increases in healthcare funding. That's why it was so important for you, the federal deputies who are here, and the National Congress, to have removed the spending cap on healthcare; it allowed us to invest in healthcare, because, as you say, healthcare is not an expense. Health is an investment. Health, and here is proof of that, Mr. President. Healthcare saves people's lives . It allows people to live longer. It's a relief for families' wallets, and they use that money to buy other things, and healthcare generates jobs, it generates factories like this one. It was 2023, your first year in office, Mr. President, and 19 billion was already an increase compared to 2022, and we are reaching 27 billion reais in resources in the Ministry of Health's budget for the purchase of medicines by 2026. It's more than double the KTI in 2023. That's what helps drive this economy, along with the financing from BNB, and what Apex, which is here, is doing in terms of promotion. Eurofarma is in 24 different countries, isn't that right, Mauricio? 24. Next week we're going to Mexico with them, Mr. President, they're going with us. Mexico, you have built a partnership with Mexico, with the President of Mexico, which will even lead to our Brazilian agency Anvisa, together with Anvisa of Mexico, establishing a partnership so that products registered here in Brazil can be sold directly in Mexico. This will benefit Eurofarma, the Brazilian industry, and generate more jobs and income for our workers here in our country. You can move on to the next one, folks. And this effort to increase resources is also starting to allow us to give the population access to some medications that were previously inaccessible, that people had no way of getting. I'm going to talk about a medication, Mr. President, that's currently in vogue: these so- called slimming pens. It is a medication that emerged to combat diabetes, and is very important for diabetes care. And people also realized that it can help in the fight against obesity. The World Health Organization, for the first time at the end of last year, issued a report advising countries that it was important to consider how to facilitate access for the Brazilian population to so-called slimming pens, recognizing that they can help combat obesity and related problems, such as cardiovascular issues and some types of cancer. So, as soon as the WHO released that report, Mr. President, the Ministry of Health, Anvisa, we called on national and international companies here in Brazil and asked, to issue a call for bids, who is capable of producing the semaglutide slimming pen here in Brazil, which was the subject of the patent application in 2026. And we had a very good response from national companies, from international companies, like Novo Nordesk here, which held the patent, and which partnered with the national company, which is Eurofarma, as well as companies from China and India, which submitted the Anvisa registration. We already have 14 registered products. That adds two more, Marcelo. Let's go , two more! 16. 16 registered products, that is, generic versions of the semaglutide slimming pen . Mr. President, Brazil is currently the country with the greatest diversity of registered generic medications for combating obesity, specifically the so-called "slimming pens." And that brought the price down for the population. What used to cost R$1,700 or R$2,000 is now between R$300 and R$400 at the pharmacy, increasing access. But there's something more; this already helps a lot of people, but we want something else, which is to have this medication included in the SUS (Brazilian public healthcare system) as a right. Therefore, Mr. President, the Ministry of Health has already begun working with our Hospitalar Conceição group, which is the company that manages hospitals for the Ministry of Health, on the protocol for how this medication can be used within the SUS (Brazilian Public Health System). Ali is the first patient; he authorized us to show his photo. Ali is the first one who received it. This young man here was the first to receive this medication through the SUS (Brazilian public healthcare system). He has already lost 6 kg, reducing his waist circumference. Now, what's really cool is him saying that he's already changed his lifestyle habits. He began to be able to help his mother. He was waiting in line for bariatric surgery. You can now help your mother at home. The other day he sent a message to the doctor saying : "Uncle, I was happy that I managed to buy detergent. I went to the supermarket, bought it, and came back to clean the bathroom, to help my mother clean the bathroom, because I couldn't clean the bathroom myself. He started leaving the house, doing physical activity, and we started incorporating this medication into the SUS (Brazilian Public Health System). The guarantee is only possible because our national industry, along with international partners, will produce it here in Brazil. And that's what allows us to incorporate it into the SUS responsibly. We're not going to incorporate it into the SUS as if it were a cosmetic miracle. Here at the Celar Conceição group, we're evaluating people who were on the waiting list for bariatric surgery. Using this medication, they can control obesity without needing surgery. It's better for their situation. People who have obesity and heart problems, women who have had breast cancer, and for whom the use of this medication can reduce the risk of breast cancer returning. People who need it with medical guidance. So, from here we will prepare the protocol so that we can implement it in the SUS, throughout Brazil, if you wish." And I know that you will want us to responsibly include these medications in the Unified Health System (SUS). You can move on to the next one. This partnership, Mr. President, does something else , which is that Brazil can produce high-tech, high-cost medications here, increasing our sovereignty. When we put more resources into health, as you did, when we prioritize and strengthen the SUS, we don't let the SUS suffer the cuts they want to make, and we create partnerships with national and international industry, with Anvisa and BNDES involved, we can produce the most modern, high- tech medications here in Brazil through productive development partnerships. I want to thank you because Aerofarma participates in several of them as Eurofarma and also as an associated group of Bionov, joining other national companies. We have already started producing cancer medications that we didn't produce here in Brazil. We started producing medications for diabetes, multiple sclerosis, cystic fibrosis, the vaccine I'm going to talk about for bronchiolitis, arthritis, chickenpox, guaranteeing Income, employment, technology here in Brazil, and something very important, which is sovereignty. We learned from the Covid-19 pandemic. A country cannot be dependent on others to guarantee medicines and technologies for its population. The next one can pass. Here are some milestones of this, Mr. President. One is the bronchiolitis vaccine, which we included in the SUS (Brazilian public health system), a vaccine that cost up to R$ 4,000 in some private clinics, was introduced for pregnant Brazilian women at the end of last year, and it's already the largest bronchiolitis vaccination program in the world. And this winter, this vaccine, which was introduced in December of last year, has already led to a 52% reduction in hospitalizations of babies due to illnesses caused by bronchiolitis. In other words, it's generating employment, technology, protecting pregnant women, protecting children, and the health system itself. Thanks to partnerships, Brazil has resumed producing insulin here in Brazil after 20 years. We are in Montes Claros, which is the land of the so-called Biobrás. Here was the largest Brazil's insulin factory is one of the largest in the world. This factory was deactivated due to policies that did not recognize the importance of guaranteeing national production. Thanks to the PDP (Product Development Partnership), we resumed insulin production here in Brazil. We have a large investment here in Montes Claros from Novo Nordes, which will produce insulin here at the factory, at the industrial plant. It is the largest private investment in new factories in Brazil, and we resumed insulin production thanks to the partnership with a fully national company. We were able to incorporate a medication. Mr. President, these medications cost 9 to 10 million reais per dose. Imagine if you had a child who needed to take medication that costs 9 to 10 million reais per dose. It's impossible for almost all Brazilian families. But thanks to this strategy, we managed to include this medication in the SUS (Unified Health System). Today, this medication is guaranteed for families who have this problem within the SUS. We are already the largest public program for this medication in the world. This is only possible because these partnerships invest in high-cost, high-technology medications, generating employment and income. Here in our country. The next one can pass , it's almost over here already. This complex, Mr. President, has a great challenge today. And Eurofarma has been, as Walker said here , at their research center in São Paulo, it has been a complex where innovation is its main source. And you took a very important step, which is this National Clinical Research Program. When you sanctioned the law of the new regulatory framework for clinical research. What is clinical research? For a medication that is developed to reach people in pharmacies, in the SUS (Brazilian public health system), it has to go through clinical research tests. That's where the evaluation is done to see if this medication is effective, safe, or not. The more clinical research we do in our country, in our hospitals, our services, the more we attract production here to Brazil, the more jobs, income, and international investment we generate here in Brazil. Thanks to the sanctioning of your bill, Mr. President, and the implementation we are doing in this new rule of clinical research. By 2025, Brazil will have already grown 30% in its global participation in research. The clinic is attracting over 2 billion reais in research investments here in Brazil . We were ranked 18th, we reached 12th place in the first half of this year, and our fight is among the top 10. We will reach the top 10 by next year. With that, we will advance even further. And Eurofarma also helps us in this area of ​​innovation, developing a new technology that can address a serious problem that still exists in Brazil and the world, which is Chagas disease. Today, the vector of Chagas disease is in the United States. It's something that was very present here in Minas Gerais, in this region. The vector, the mosquito, the kissing bug, is in the United States because of the warming of climate change. The next one may pass . I think it's over now. So, I wanted to say to everyone, Mr. President, and tell you something, why do they invest here in Montes Claros? First, because of SUDENE and BNB, because you defend SUDENE, because the Brazilian Northeast, these isolated areas... They need priority attention from the Brazilian economy and people . You defended the BNB, which is a public bank, you defend public banks, which is what provides financing here. The second reason, Mr. President, is that you doubled the highway, the doubling from here to Belo Horizonte, the doubling from here to Governador Valadares, financed by the BNDES, provides a very important drainage route for this region, facilitating its introduction. And the third is that Montes Claros has become a major educational hub, thanks to Proi, FIES, investment in education, and the strengthening of science. Did you hear from one of the directors here at Eurofarma before construction began? No, it wasn't her, it wasn't Renata, she's over there. She went to each college here, to the universities, to discuss and create a specific course to train professionals for this region. And this hub will be even stronger, because last week Saria Felipe made me go to the Santa Casa de Montes Claros here, folks. We went to see it, and they have all the criteria to create a new medical school. Here in Montes Claros, starting with the Santa Casa hospital, we invest in health, education, the business environment, and public banks. We make this country grow, everyone wins, people live longer and better lives with easier wallets, thanks to the SUS (Brazilian Public Health System). A big hug to everyone here at Eurofar. Ladies and gentlemen, the floor is yours, President of the Republic, Luís Inácio Lula da Silva. [applause] Well, you noticed that Padilha didn't leave anything for me to say, and if I were to talk about health here, I would n't get to. I just wanted to greet the colleagues who are here. My Minister of Health, Padilha; Alexandre Silveira, from Mines and Energy; my colleague Sarava Felipe, who was also my Minister of Health from 2005 to 2006; federal deputies Dandara, Leonardo Monteiro, Paulo Guedes, Patru Ananias, and Geraldo Lopes. I also want to greet the president of the Banco do Nordeste, Paulo Câmara; Laudemir Multe from PEX Brasil; and Maurício Billy, president of... Eurofarma, Marco B, international CEO of Eurofarma, Walker Magalhães, executive director of institutional relations, and Roberta Costa de Souza Rezende, vice president of operations at Eurofarma, want to tell you the following: What is happening in Brazil today is only happening because there is a group of people working to believe that our country has a future. When we created the new Brazilian industry, which is a complex of six industries, one of them being the health industry, we could only think about creating a health pardon here in Brazil because we have an extraordinary consumer, which is the SUS (Unified Health System). The SUS means that Brazil, as a country with more than 100 million inhabitants, has the only unified health system on planet Earth. And here everyone is treated equally by the SUS, especially in the Farmácia Popular (Popular Pharmacy) program. We don't ask for payment, we don't ask for anyone's payslip. If the person has a prescription, they go there and buy the medicine. It applies to the banker and it applies to the bank employee. It applies to the sugarcane cutter and it applies to the worker. For the owner of the sugar mill. In other words, in a demonstration that we do n't discriminate when it means giving life to people. By the way, Padilha, that day I was accused by my doctor of being responsible for the increased longevity of the Brazilian people. Because people are eating more, people are having free medicine, people are taking better care of themselves, people are living longer. And people living longer will give more work to the SUS (Brazilian Public Health System). The SUS will have to hire more companies, will have to buy more medicine, and people will live longer. I was born in a time, Padilha, when people aged 42 were considered old. At 60, they were at the end of their rope. And now, at 80, I feel like a young 80-year-old. It's very important that we take into account those who didn't believe, those who didn't believe in resurrection, can believe. Not in a person, but in the SUS. I was a constituent deputy, I don't know if Saraiva was, creating the SUS. I was part of the group of deputies who created the SUS in '88. After we created the SUS, the SUS underwent a... A barrage of criticism from the private sector. The private sector didn't want us to create the SUS [clearing throat] and didn't want the State to show Brazilian society that the Unified Health System could work. And often the press treated the SUS very badly. The press never took into account how many people the SUS saved. They only announced the people who had died, which was to create a negative image of the Unified Health System. And in Brazil, many people who had never used the SUS thought that the SUS was what the press said. Then came COVID, and who showed their face? Who saved this country from an even greater disaster? It was exactly the SUS. The doctors of the SUS, the nurses of the SUS, the ambulance drivers of the SUS, these people putting their lives at risk. It was they who prevented us from having more than 1 million deaths instead of 716,000. And you know that the number of People who died did so because we didn't have a health minister like Padilha. We had a general named Pasoelo, who understood everything except medicine in this country. He understood everything except the SUS (Brazilian public healthcare system), he understood everything except the politics of treating human beings with respect. And today the SUS has resurfaced, but it has resurfaced with much greater strength, much greater. Today the SUS is able to show the world that few private places offer the things that the SUS offers to the people. Today, the cancer treatment that Padilha showed there, the most humble people have the right to the same treatment, to use the same medicine and the same machines that were previously only for the rich. Now I say to everyone, if a poor person from Montes Claros needs radiotherapy, they will have it done on a machine exactly like the one Trump will use in the United States, exactly like the one Fijipin will use in China, exactly like the one Lula will use in Brasília. That's called dignity for the humble people of this country. When we decide to provide free medicine for the people, especially medicine for continuous use, it's because you... You know that in your families, in your families, you already know news of people who died because they did n't have money to buy medicine. People who died of cancer because they did n't have money to pay for the necessary tests. People who died of heart attacks because they didn't have an ambulance like Sabu to pick them up on the road or in a poor neighborhood and take them to the hospital. People died mostly due to negligence on the part of the Brazilian state. And when I took office as president, I told Padilha: "Health is a right for everyone, not a privilege for those who have money." It is a right of every person. No matter how humble she may be, regardless of her color, religion, or gender, she has the right to treatment that gives her the certainty that she will survive because she is being well cared for. That's what the SUS (Brazilian public healthcare system) is all about, Padilha . [snoring] When I called on my colleague Nívia to be Minister of Health, Nívia was a colleague who had been president of Fiocruz in Rio de Janeiro. She wasn't a doctor. But I spoke with several of my former ministers and told them I was going to choose Nívia from the C group, and I gave Nívia a mission. For God's sake, I want people to have a second consultation, and after the second consultation, I want people to give up the machine, because that's how the SUS (Brazilian public healthcare system) used to be: you'd go to an emergency care unit, go to a primary care unit, leave with the consultation, have no money, and die. We started giving him the medicine. Then, after the consultation, the person would buy the medication, but they still had to see a specialist. And it took a year to schedule an appointment with the specialist. When he was an expert, he asked for any machine . Any old machine. I always mention MRI because it's the most annoying machine in the world, where you're stuck inside for 40 minutes feeling like you've been buried alive. If a person were to request a machine to perform a more thorough examination of the heart, it would take another year. One year for the consultation, one year for the specialist, and one year for Marcos. People died, and we decided to tell the Brazilian people that health is not treated according to people's birth certificates, it is not treated according to the cradle they were born into, it is treated according to the severity of the person's need to have access to the necessary medicine. And that is why the SUS (Brazilian Public Health System) is respected throughout the world today. Worldwide. I made a point of bringing the Director-General of the World Health Organization with me to Rio de Janeiro to visit a mobile health unit, the so-called "health truck," especially for women. She does all the tests to find out if the woman has cancer, you know? Well, talk to everyone if there are gynecological problems, do a colposcopy to see if there are problems with the cervix, and a transvaginal ultrasound. Pelvic ultrasound, mammography. Mammography performs the biopsy. You go there right away, you take the test, and you leave with the results on your cell phone. What does this mean? dignity. And when we have entrepreneurs who believe that there is a market here in Brazil for them to invest and produce that product, and the State positions itself as a buyer, because if there are no buyers, there is no one to invest. His need to invest in this factory stems from the knowledge that there is a consumer base for the product he is going to make. And the SUS (Brazilian Public Health System) is the guarantee that when the medicine is made, the SUS buys it to deliver it free of charge to the Brazilian people. This doesn't exist in almost any other country in the world. In almost no country in the world. I'm going to tell you a story, you're a businessman who came here from Italy. The other day, the newspaper Globo published an article by an American journalist who was in Rio de Janeiro. He went to Ilha Bela. His son fell ill on Ilha Bela . He went to his car to get some medicine for his son. When he opened the trunk of the car, the trunk lid slammed shut, causing a hole in his head. He started bleeding heavily. Called aô. He couldn't believe he had a free ambulance. Call an ambulance. The ambulance picked him and his son up, and he was inside the ambulance looking worried. How am I going to pay? In the United States, an ambulance should cost around 10,000. How am I going to pay? The SAMU ambulance took him to the hospital, where he received eight stitches to the head. Taking care of his son. When he went to ask how much it cost, he received the answer: "It costs nothing here. We don't even care if you're American. We want to know that you needed the SUS (Brazilian public healthcare system) and the SUS provided it. This is the country we are building, this country. I'll tell you something, my friend, moving away from the topic of medicine. Yesterday I signed a law, a law called Redata. What is Redata? Redata is an authorization for us to put data centers into operation here in Brazil, this world of information, this world of artificial intelligence, something so talked about and so unknown, Brazil can receive 1 trillion dollars in investment over time. Why? Because Brazil is the only country in the world that has the ease of producing renewable energy, wind energy, solar energy, energy through ethanol, energy through gas. And the companies that want to come here have to build the energy they will consume, because the so-called data center consumes a lot of energy and we are not going to mix them. The energy that the state produces is for..." People, it's for your home, for your television, for your computer. To make money with data centers, they have to [clearing throat] make the investment. This will be an extraordinary investment in Brazil. I think that Brazil will transform itself over time into the data center of this world, the country of information. And we also want a data center, because we want to do artificial intelligence in Portuguese. We don't want to keep copying the Chinese and the Americans. We want a Portuguese one. And if you are an expert, you can help us create our own artificial intelligence. But yesterday also, [applause] yesterday I sanctioned the law and signed the decree creating the council for something called rare earths and critical minerals. Yesterday I signed the law. I created a council with representatives from entities, universities, and specialists, and I created a special council for myself, a council of four people who will be my special advisors so that neither the Chinese nor the Americans take our rare earths, because they are ours, they are the passport to the future of our people. And so we assume the responsibility. We will not We want to be exporters of raw materials, but we want to be exporters of processed products so that we can make money. Yesterday I read a text by Galeano, a great Uruguayan journalist and writer. He compared minerals to gold and said: "In the gold rush era, Brazil was left with a hole, Portugal was left with a castle, and England created industrial policy." We're not going to leave a hole like this now. We're going to stick with our critical minerals. We will train our youth, we will train geophysical engineers, we will train researchers, and we will transform this place and sell finished products. Because this so-called critic, whom I thought was bad land, is actually good land; it's land that produces electric car batteries, land that allows for the production of chips, cell phones, all those fancy things that Trump is fighting with the United States about. We are going to create a product here in Brazil called "Made in Brazil," which uses artificial intelligence to exploit critical analysis of young people. Furthermore, I also had some news this week: we just found another pre-salt oil field on the equatorial margin, 575 km from the coast of the Amazon and 175 km from Mapá. I went there to visit a platform 175 km from the sea. At this platform, our station is already 7,000 m deep. 7,000 m. We're going to dig three more wells. And the oil is of good quality. And you can be sure that this oil will not cause any pollution problems in the sea. Because Petrobras has a machine that it places near the well. If there's a leak, this machine shuts off the well immediately. We don't run the risk of what happened in the Gulf of Mexico with that English company happening here in Brazil. And the money from the tax breaks will be used for education, science and technology, and health, because it will be used to improve the lives of the Brazilian people. Look how funny. The Padilha shipbuilding industry, which when I was in government first had 82,000 workers. When I won in 2002, she had 6,000. We reached 82,000. I left the government, they ousted Dilma, they staged a coup against Dilma. It dropped from 82 to 15. I'm going to have it now, the naval shipyard already has 75,000 workers and we're going to generate many more, because we also want to produce the ships here, we want to produce platforms here, we want to produce from here because we don't want to be dependent on anyone. All of this is happening in Brazil, with the SUS (Brazilian public healthcare system) doing what it's doing, with industry believing in Brazil and coming here because they believe there will be buyers; in other words, they made it, sold it, received payment, and the people were saved. That is the motto of our country. So, Padilha, congratulations. Do you want to see what you're going to do for the pharmacy? Oh, no. And now there's more, folks. That little pen he was talking about, the magic pen. First, Padilha, you have to do me a favor. The doctors need to reach an agreement with the doctors, because you can't keep redoing the pen to the tower properly. In other words, we have to make a difference. Some people need to be re-educated about their eating habits in order to lose weight. She needs to relearn how to eat things that are good for her health. Second, get some exercise. Do some exercise. Oh, folks, I'm 80 years old. I wake up every day at 5:30 in the morning and sleep for 2 hours, man. Two more hours. Do you know why I love the sea? Because I want to live. I enjoy life. So I have to take care of myself. Who will take care of me? Me. So I do two hours. I'm short, 2 hours, I do a lot of leg exercises, I work my calves, I just don't do squats because I'm not interested in making them bigger, [laughs] but I do a lot of squats too, a lot of squats, and I'm running at 8 km/h, okay? It's important. I can run at 8 km/h, which means if I can, you can, it means you can, if I can, you can. It's all about wanting it. At first you'll be lazy. At first you'll stay here, I'll stay in bed, my leg hurts. But when you realize that you're avoiding spending money on doctors because you're taking care of yourself, you'll make an effort for yourself. It means taking care of ourselves. And even more so , especially the doctors. I think the doctor should act right away—I'm not a doctor, but you are a doctor. I think that when a doctor gives a prescription, they should say: "Look, my son, you need to change your diet. You can't eat too much bacon, you can't eat too much fat, you can't eat too much fried food, you need to eat healthier, try to eat more organic food, have better quality food, don't buy canned goods, [laughs] don't keep stuffing yourself with those greasy hamburgers. No, eat something healthier, like some sun-dried beef from Monte Claros." Well, I think if doctors contribute, it will be very good. I think that when we leave the doctor's office, we should leave with the doctor, we should have a physiotherapist nearby to tell us what to do, right ? And there should be a nutritionist to say: "Look, you have to eat this, because otherwise we have to pay for the doctor's appointment, then pay separately for the nutritionist's appointment, and then pay separately for the consultation, you know?" A physiotherapist there is too much. Three appointments for the same thing is too much. I hope that the day will come and that we will succeed. But what's important is that this little pen will be used to provide free care for people who are obese, okay? When the doctor detects that a man or woman has trouble healing. The other day I met a mayor, and he weighed 205 kg. He weighed 205. Padilha, today he weighs 105. Do you know how much skin he had removed from his body? 15 kg. He pulled a Lula out of himself, you know? So doctors also have to contribute because soon there will be people handing out pens to everyone, and there will be congressmen and candidates throwing pens to the people. The pen isn't like that here. That's irresponsible, because a person needs to know, and understands, whether or not they can take it, whether it will be good for their health or not. If the person is a young, healthy woman from Brasília, then go for it, damn it. You'll walk, you'll buy bread on foot, you'll go on dates on foot, you'll do everything on foot, you don't need to go by car. So, that's why you're acting like this, being so picky. And that. So, Padilha, I want to say this to you, I mean to my colleagues. I feel proud. If there's one thing I'm proud of in life, it's seeing someone succeed, you know? I know the effort you made to follow in your father's footsteps, and I know how naturally beautiful you are. A factory that can be a source of pride for Brazil, in any country in the world. So, congratulations, may God bless you, and congratulations, congratulations to the employees who work with you, [applause] because a company like this will generate specialist training here. We are going to build the university hospital here in this city. You'll get more skilled jobs. With a more skilled job, you'll have a better salary. It's not that? For a man to take care of his family decently, and for a woman to earn well so she doesn't have to suffer disrespect from any man. She has to walk with her head held high, inside the house, because there's nothing worse than depending on a duck for food that someone else will give her. So, folks, may God bless you. Believe me, there's no going back for this country. It's from here on out. We are going to transform this country into a highly developed nation in the next 10 years. We've had enough of looking at Shanghai, enough of looking at the Bell Valley, enough of looking at who knows who. Let's look at ourselves with pride. Each of us will wake up in the morning, look in the mirror and say: "I am no worse than anyone else, nor do I want to be better, I just want to be equal. I am Brazilian and I am proud and I will never give up. This country will be a great country. A kiss on the heart and until another day. These interventions are concluded. Everyone is asked to wait in their seats for the departure of the President of the Republic."